Epilepsy is a complex disorder affecting the central nervous system and is characterised by spontaneously recurring seizures (SRSs). Epileptic patients undergo symptomatic pharmacological treatments, however, in 30% of cases, they are ineffective, mostly in patients with temporal lobe epilepsy. Therefore, there is a need for developing novel treatment strategies. Transplantation of cells releasing γ-aminobutyric acid (GABA) could be used to counteract the imbalance between excitation and inhibition within epileptic neuronal networks. We generated GABAergic interneuron precursors from human embryonic stem cells (hESCs) and grafted them in the hippocampi of rats developing chronic SRSs after kainic acid-induced status epilepticus. Using whole-cell patch-clamp recordings, we characterised the maturation of the grafted cells into functional GABAergic interneurons in the host brain, and we confirmed the presence of functional inhibitory synaptic connections from grafted cells onto the host neurons. Moreover, optogenetic stimulation of grafted hESC-derived interneurons reduced the rate of epileptiform discharges in vitro. We also observed decreased SRS frequency and total time spent in SRSs in these animals in vivo as compared to non-grafted controls. These data represent a proof-of-concept that hESC-derived GABAergic neurons can exert a therapeutic effect on epileptic animals presumably through establishing inhibitory synapses with host neurons.

Department of Physiology 2nd Faculty of Medicine Charles University 150 06 Prague Czech Republic

Epilepsy Center Department of Clinical Sciences Lund University Hospital 221 84 Lund Sweden

See more in PubMed

Beghi E., Giussani G., Abd-Allah F., Abdela J., Abdelalim A., Abraha H.N., Adib M.G., Agrawal S., Alahdab F., Awasthi A., et al. Global, regional, and national burden of epilepsy, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:357–375. doi: 10.1016/S1474-4422(18)30454-X. PubMed DOI PMC

Toda Y., Kobayashi K., Hayashi Y., Inoue T., Oka M., Ohtsuka Y. Effects of intravenous diazepam on high-frequency oscillations in EEGs with CSWS. Brain Dev. 2013;35:540–547. doi: 10.1016/j.braindev.2012.09.002. PubMed DOI

Peng B.-W., Justice J.A., Zhang K., Li J., He X., Sanchez R.M. Gabapentin promotes inhibition by enhancing hyperpolarization-activated cation currents and spontaneous firing in hippocampal CA1 interneurons. Neurosci. Lett. 2011;494:19–23. doi: 10.1016/j.neulet.2011.02.045. PubMed DOI

Braga M.F.M., Aroniadou-Anderjaska V., Li H., Rogawski M.A. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J. Pharmacol. Exp. Ther. 2009;330:558–566. doi: 10.1124/jpet.109.153908. PubMed DOI

Ylinen A., Valjakka A., Lahtinen H., Miettinen R., Freund T.F., Riekkinen P. Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path. Neuropeptides. 1991;19:205–211. doi: 10.1016/0143-4179(91)90120-8. PubMed DOI

O’Brien T.J., Ben-Menachem E., Bertram E.H., Collins S.D., Kokaia M., Lerche H., Klitgaard H., Staley K.J., Vaudano E., Walker M.C., et al. Proposal for a “phase II” multicenter trial model for preclinical new antiepilepsy therapy development. Epilepsia. 2013;54:70–74. doi: 10.1111/epi.12300. PubMed DOI

Chen B., Choi H., Hirsch L.J., Katz A., Legge A., Buchsbaum R., Detyniecki K. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24–31. doi: 10.1016/j.yebeh.2017.08.039. PubMed DOI

Strine T.W., Kobau R., Chapman D.P., Thurman D.J., Price P., Balluz L.S. Psychological Distress, Comorbidities, and Health Behaviors among U.S. Adults with Seizures: Results from the 2002 National Health Interview Survey. Epilepsia. 2005;46:1133–1139. doi: 10.1111/j.1528-1167.2005.01605.x. PubMed DOI

Cramer J.A., Steinborn B., Striano P., Hlinkova L., Bergmann A., Bacos I., Baukens C., Buyle S. Non-interventional surveillance study of adverse events in patients with epilepsy. Acta Neurol. Scand. 2011;124:13–21. doi: 10.1111/j.1600-0404.2010.01440.x. PubMed DOI

Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet. 2006;367:1087–1100. doi: 10.1016/S0140-6736(06)68477-8. PubMed DOI

Engel J. Epilepsy in the world today: The medical point of view. Epilepsia. 2002;43:12–13. doi: 10.1046/j.1528-1157.43.s.6.6.x. PubMed DOI

Marcangelo M.J., Ovsiew F. Psychiatric Aspects of Epilepsy. Psychiatr. Clin. N. Am. 2007;30:781–802. doi: 10.1016/j.psc.2007.07.005. PubMed DOI

Engel J., McDermott M.P., Wiebe S., Langfitt J.T., Stern J.M., Dewar S., Sperling M.R., Gardiner I., Erba G., Fried I., et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: A randomized trial. JAMA J. Am. Med. Assoc. 2012;307:922–930. doi: 10.1001/jama.2012.220. PubMed DOI PMC

Yilmazer-Hanke D.M., Wolf H.K., Schramm J., Elger C.E., Wiestler O.D., Blümcke I. Subregional Pathology of the Amygdala Complex and Entorhinal Region in Surgical Specimens from Patients with Pharmacoresistant Temporal Lobe Epilepsy. J. Neuropathol. Exp. Neurol. 2000;59:907–920. doi: 10.1093/jnen/59.10.907. PubMed DOI

Ziburkus J., Cressman J.R., Barreto E., Schiff S.J. Interneuron and pyramidal cell interplay during in vitro seizure-like events. J. Neurophysiol. 2006;95:3948–3954. doi: 10.1152/jn.01378.2005. PubMed DOI PMC

Bausch S.B. Axonal sprouting of GABAergic interneurons in temporal lobe epilepsy. Epilepsy Behav. 2005;7:390–400. doi: 10.1016/j.yebeh.2005.07.019. PubMed DOI

Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus. 1998;6:347–470. doi: 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I. PubMed DOI

Liu Y.Q., Yu F., Liu W.H., He X.H., Peng B.W. Dysfunction of hippocampal interneurons in epilepsy. Neurosci. Bull. 2014;30:985–998. doi: 10.1007/s12264-014-1478-4. PubMed DOI PMC

Zhang W., Yamawaki R., Wen X., Uhl J., Diaz J., Prince D.A., Buckmaster P.S. Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. J. Neurosci. 2009;29:14247–14256. doi: 10.1523/JNEUROSCI.3842-09.2009. PubMed DOI PMC

Sun C., Mtchedlishvili Z., Bertram E.H., Erisir A., Kapur J. Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation-based animal model of temporal lobe epilepsy. J. Comp. Neurol. 2007;500:876–893. doi: 10.1002/cne.21207. PubMed DOI PMC

Hunt R.F., Girskis K.M., Rubenstein J.L., Alvarez-Buylla A., Baraban S.C. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat. Neurosci. 2013;16:692–697. doi: 10.1038/nn.3392. PubMed DOI PMC

Waldau B., Hattiangady B., Kuruba R., Shetty A.K. Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells. 2010;28:1153–1164. doi: 10.1002/stem.446. PubMed DOI PMC

Casalia M.L., Howard M.A., Baraban S.C. Persistent seizure control in epileptic mice transplanted with gamma-aminobutyric acid progenitors. Ann. Neurol. 2017;82:530–542. doi: 10.1002/ana.25021. PubMed DOI PMC

Henderson K.W., Gupta J., Tagliatela S., Litvina E., Zheng X., Van Zandt M.A., Woods N., Grund E., Lin D., Royston S., et al. Long-Term Seizure Suppression and Optogenetic Analyses of Synaptic Connectivity in Epileptic Mice with Hippocampal Grafts of GABAergic Interneurons. J. Neurosci. 2014;34:13492–13504. doi: 10.1523/JNEUROSCI.0005-14.2014. PubMed DOI PMC

Baraban S.C., Southwell D.G., Estrada R.C., Jones D.L., Sebe J.Y., Alfaro-Cervello C., Garcia-Verdugo J.M., Rubenstein J.L.R., Alvarez-Buylla A. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc. Natl. Acad. Sci. USA. 2009;106:15472–15477. doi: 10.1073/pnas.0900141106. PubMed DOI PMC

Hattiangady B., Rao M.S., Shetty A.K. Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp. Neurol. 2008;212:468–481. doi: 10.1016/j.expneurol.2008.04.040. PubMed DOI PMC

Cunningham M., Cho J.-H., Leung A., Savvidis G., Ahn S., Moon M., Lee P.K.J., Han J.J., Azimi N., Kim K.-S., et al. hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell. 2014;15:559–573. doi: 10.1016/j.stem.2014.10.006. PubMed DOI PMC

Upadhya D., Hattiangady B., Castro O.W., Shuai B., Kodali M., Attaluri S., Bates A., Dong Y., Zhang S.C., Prockop D.J., et al. Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proc. Natl. Acad. Sci. USA. 2019;116:287–296. doi: 10.1073/pnas.1814185115. PubMed DOI PMC

Gonzalez-Ramos A., Waloschková E., Mikroulis A., Kokaia Z., Bengzon J., Ledri M., Andersson M., Kokaia M. Human stem cell-derived GABAergic neurons functionally integrate into human neuronal networks. Sci. Rep. 2021;11:1–16. doi: 10.1038/s41598-021-01270-x. PubMed DOI PMC

Yang N., Chanda S., Marro S., Ng Y.H., Janas J.A., Haag D., Ang C.E., Tang Y., Flores Q., Mall M., et al. Generation of pure GABAergic neurons by transcription factor programming. Nat. Methods. 2017;14:621–628. doi: 10.1038/nmeth.4291. PubMed DOI PMC

Allison T., Langerman J., Sabri S., Otero-Garcia M., Lund A., Huang J., Wei X., Samarasinghe R.A., Polioudakis D., Mody I., et al. Defining the nature of human pluripotent stem cell-derived interneurons via single-cell analysis. Stem Cell Rep. 2021;16:2548–2564. doi: 10.1016/j.stemcr.2021.08.006. PubMed DOI PMC

Shrestha S., Anderson N.C., Grabel L.B., Naegele J.R., Aaron G.B. Development of electrophysiological and morphological properties of human embryonic stem cell-derived GABAergic interneurons at different times after transplantation into the mouse hippocampus. PLoS ONE. 2020;15:e0237426. doi: 10.1371/journal.pone.0237426. PubMed DOI PMC

Anderson N.C., Van Zandt M.A., Shrestha S., Lawrence D.B., Gupta J., Chen C.Y., Harrsch F.A., Boyi T., Dundes C.E., Aaron G., et al. Pluripotent stem cell-derived interneuron progenitors mature and restore memory deficits but do not suppress seizures in the epileptic mouse brain. Stem Cell Res. 2018;33:83–94. doi: 10.1016/j.scr.2018.10.007. PubMed DOI

Palma E., Amici M., Sobrero F., Spinelli G., Di Angelantonio S., Ragozzino D., Mascia A., Scoppetta C., Esposito V., Miledi R., et al. Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc. Natl. Acad. Sci. USA. 2006;103:8465–8468. doi: 10.1073/pnas.0602979103. PubMed DOI PMC

Huberfeld G., Wittner L., Clemenceau S., Baulac M., Kaila K., Miles R., Rivera C. Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J. Neurosci. 2007;27:9866–9873. doi: 10.1523/JNEUROSCI.2761-07.2007. PubMed DOI PMC

Bregestovski P., Bernard C. Excitatory GABA: How a correct observation may turn out to be an experimental artifact. Front. Pharmacol. 2012;3:65. doi: 10.3389/fphar.2012.00065. PubMed DOI PMC

Maglóczky Z.S., Wittner L., Borhegyi Z.S., Halász P., Vajda J., Czirják S., Freund T.F. Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience. 2000;96:7–25. doi: 10.1016/S0306-4522(99)00474-1. PubMed DOI

Tóth K., Maglóczky Z. The vulnerability of calretinin-containing hippocampal interneurons to temporal lobe epilepsy. Front. Neuroanat. 2014;8:100. doi: 10.3389/fnana.2014.00100. PubMed DOI PMC

Lentini C., D’Orange M., Marichal N., Trottmann M.-M., Vignoles R., Foucault L., Verrier C., Massera C., Raineteau O., Conzelmann K.-K., et al. Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy. Cell Stem Cell. 2021;28:2104–2121.e10. doi: 10.1016/j.stem.2021.09.002. PubMed DOI PMC

Zhang F., Wang L.P., Brauner M., Liewald J.F., Kay K., Watzke N., Wood P.G., Bamberg E., Nagel G., Gottschalk A., et al. Multimodal fast optical interrogation of neural circuitry. Nature. 2007;446:633–639. doi: 10.1038/nature05744. PubMed DOI

Lockowandt M., Günther D.M., Quintino L., Breger L.S., Isaksson C., Lundberg C. Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector. J. Neurosci. Methods. 2020;336:108542. doi: 10.1016/j.jneumeth.2019.108542. PubMed DOI

Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294. doi: 10.1016/0013-4694(72)90177-0. PubMed DOI

Nikitidou Ledri L., Melin E., Christiansen S.H., Gøtzsche C.R., Cifra A., Woldbye D.P.D., Kokaia M. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors. Neurobiol. Dis. 2016;86:52–61. doi: 10.1016/j.nbd.2015.11.014. PubMed DOI

GitHub—AMikroulis/xPSC-Detection: Template Correlation-Based Detection of Postsynaptic Currents. [(accessed on 22 November 2021)]. Available online: https://github.com/AMikroulis/xPSC-detection.

Pistis M., Belelli D., Peters J.A., Lambert J.J. The interaction of general anaesthetics with recombinant GABA(A) and glycine receptors expressed in Xenopus laevis oocytes: A comparative study. Br. J. Pharmacol. 1997;122:1707–1719. doi: 10.1038/sj.bjp.0701563. PubMed DOI PMC

Das P., Bell-Horner C.L., Machu T.K., Dillon G.H. The GABAA receptor antagonist picrotoxin inhibits 5-hydroxytryptamine type 3A receptors. Neuropharmacology. 2003;44:431–438. doi: 10.1016/S0028-3908(03)00032-7. PubMed DOI

Das P., Dillon G.H. Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. J. Pharmacol. Exp. Ther. 2005;314:320–328. doi: 10.1124/jpet.104.080325. PubMed DOI

Chemogenetics with PSAM4-GlyR decreases excitability and epileptiform activity in epileptic hippocampus